Valuation: genedrive plc

Market Cap 20.87M 28.28M 24.42M 22.95M 39.24M 2.7B 39.89M 269M 105M 1.35B 106M 104M 4.5B P/E 2024
-0.35x
P/E 2025 -1.51x
Enterprise Value 19.69M 26.68M 23.04M 21.65M 37.02M 2.55B 37.63M 254M 99.19M 1.28B 100M 97.98M 4.24B EV / Sales 2024
7.57x
EV / Sales 2025 7.93x
Free-Float
36.5%
Yield 2024 *
-
Yield 2025 -
Current month+20.00%
3 months+11.63%
6 months+9.09%
Current year+37.14%
1 week 1.15
Extreme 1.15
1.26
1 month 0.95
Extreme 0.95
1.26
Current year 0.75
Extreme 0.75
1.5
1 year 0.19
Extreme 0.19
1.5
3 years 0.19
Extreme 0.19
14.8
5 years 0.19
Extreme 0.19
82
10 years 0.19
Extreme 0.19
302.6
Manager TitleAgeSince
Chief Executive Officer 56 2024-08-05
Director of Finance/CFO 48 2022-04-06
Director TitleAgeSince
Director/Board Member 69 2018-04-08
Director/Board Member 52 2018-08-21
Director/Board Member 56 2023-09-10
Date Insider Type Main position Quantity % Market Cap.
12/20/24 Buy

Chief Financial Officer

1,000,000 0.1841%
12/20/24 Free 400,000 0.0736%
12/20/24 Buy

Chief Executive Officer

1,135,208 0.2090%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%0.00%+41.18%-89.47% 26.1M
+1.02%+2.28%+20.16%-35.78% 17.1B
-2.98%+0.45%-10.29%+98.24% 1.76B
-0.44%-2.23%-26.22%+23.25% 985M
-5.24%+16.40%-44.85%-80.13% 981M
-0.05%+48.99%+70.10%-6.47% 779M
+0.95%+2.45%-36.26%-50.06% 696M
+3.92%+17.79%-35.32%-38.92% 646M
+5.89%+6.05%-40.58%-36.15% 443M
-0.99%+12.73%+50.98%+43.00% 414M
Average +0.21%+10.60%-1.11%-17.25% 2.38B
Weighted average by Cap. +0.50%+5.04%+11.23%-23.50%

Financials

2024 2025
Net sales 501K 679K 586K 551K 942K 64.9M 957K 6.45M 2.52M 32.5M 2.55M 2.49M 108M 954K 1.29M 1.12M 1.05M 1.79M 124M 1.82M 12.29M 4.81M 61.89M 4.85M 4.75M 206M
Net income -7.08M -9.59M -8.28M -7.78M -13.3M -917M -13.52M -91.15M -35.64M -459M -35.99M -35.21M -1.53B -5.23M -7.09M -6.12M -5.75M -9.83M -678M -10M -67.39M -26.35M -339M -26.61M -26.03M -1.13B
Net Debt -5.17M -7M -6.05M -5.68M -9.72M -670M -9.88M -66.6M -26.04M -335M -26.29M -25.72M -1.11B -1.18M -1.6M -1.38M -1.3M -2.22M -153M -2.26M -15.23M -5.95M -76.68M -6.01M -5.88M -255M
Logo genedrive plc
genedrive plc is a United Kingdom-based pharmacogenetic testing company. The Company is engaged in developing and commercializing a rapid, versatile, simple to use and robust point-of-need pharmacogenetic platform for the diagnosis of genetic variations. The Company’s products include Genedrive MT-RNR1 ID Kit, Genedrive System, and Genedrive CYP2C19 ID Kit. The Company’s flagship product Genedrive MT-RNR1 ID Kit is a single-use disposable cartridge that circumvents the requirement for cold chain logistics by providing temperature stable reagent test kits for use on their proprietary test platform. The Genedrive System is a rapid thermocycler and signal detection system, enabling PCR and isothermal based amplification techniques. It is a semi- automated system used for qualitative in vitro molecular diagnostic tests. Its Genedrive CYP2C19 ID Kit Molecular point-of-care test for rapid CYP2C19 genotyping in time-critical emergency care settings.
Employees
43
Date Price Change Volume
26-08-14 GBX 1.200 0.00% 3,614,724
26-08-13 GBX 1.200 0.00% 606,355
26-08-12 GBX 1.200 0.00% 601,916
26-08-11 GBX 1.200 +4.35% 5,900,941
26-08-10 GBX 1.150 -4.17% 1,819,800

Annual profits - Rate of surprise